Humira’s Rich Media Banner (Moderate to Severe RA Indication)

Brand: Humira (adalimumab), Injection
Parent Company: Abbvie
Drug Type: Boxed Warning
Drug Category: Multiple Indications/Therapeutic Areas
Campaign: Post-Launch
Targeting: Patients
Patient Website:
HCP Website:

Humira utilized the rich-media (expandable) banner ad format to connect the unbranded ad to the branded one. The latter comes in after a roll-over, and takes advantage of a larger real estate. Note: we tested this ad on a mobile version of (on an iPhone), and roll-over and click did not work.